Skip to main content
Caplight Logo









REPROSENT

REPROSENT

Private
Los Gatos, CaliforniaHealthcare & Life Scienceshttps://reprosent.com/

Last Round

Grant

Aug 8, 2022

Est. Valuation

$1.79M

Total Funding Raised

$350,000

Company Overview

REPROSENT is a healthcare technology company that provides a patient-driven care system for oncology patients to track symptoms and share data with their medical teams.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Infrastructure

Keywords

patient-reported outcomesPROoncology clinical trialsdigital healthsymptom monitoringePROclinical researchhealthcare analyticsEHR-agnosticpatient engagementvertical SaaStolerability monitoringclinical data platformreal-world evidenceRWEdata as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

REPROSENT Comparables

Compare REPROSENT with similar companies based on industry and business-model similarity.

REPROSENT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Px HealthCare
83%
Health Catalyst
78%
Canopy
78%

REPROSENT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 8, 2022
AcceleratorAug 31, 2021
SeedMar 23, 2021

Key People

Founding team and executive leadership

Aimée DeGolyer

Founder CEO

Founding Team

REPROSENT Investors

Notable investors and investment history

REPROSENT investors
InvestorRounds
Y CombinatorAccelerator, Seed
Hustle FundSeed
BONDSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2021

    $125K raised from Y Combinator

REPROSENT Filings

Explore SEC and related filing metadata, where available.

REPROSENT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about REPROSENT's valuation, stock price, and market status.

Is REPROSENT a public or private company?

REPROSENT is a private company.

What is the current stock price of REPROSENT?

REPROSENT is a private company with no public stock price. No recent secondary market data is available.

How much is REPROSENT worth (valuation)?

Valuation information for REPROSENT is not publicly available.

Can I buy REPROSENT stock?

REPROSENT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was REPROSENT's last funding round?

REPROSENT's most recent funding round was Grant on August 8, 2022.

Who are the main investors in REPROSENT?

Key investors in REPROSENT include Y Combinator.

Will REPROSENT IPO soon?

No public IPO plans have been announced for REPROSENT.

How can I track REPROSENT secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor REPROSENT's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Gatos, California
Employee Range3
Year Founded2020
Last FundingAug 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?